ATE87335T1 - Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686. - Google Patents

Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.

Info

Publication number
ATE87335T1
ATE87335T1 AT87112861T AT87112861T ATE87335T1 AT E87335 T1 ATE87335 T1 AT E87335T1 AT 87112861 T AT87112861 T AT 87112861T AT 87112861 T AT87112861 T AT 87112861T AT E87335 T1 ATE87335 T1 AT E87335T1
Authority
AT
Austria
Prior art keywords
proportion
common component
antibiotic complex
selective increase
major common
Prior art date
Application number
AT87112861T
Other languages
English (en)
Inventor
Giancarlo Lancini
Piero Antonini
Angelo Borghi
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE87335T1 publication Critical patent/ATE87335T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT87112861T 1986-09-11 1987-09-03 Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686. ATE87335T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868621911A GB8621911D0 (en) 1986-09-11 1986-09-11 Increasing ratio of components of anti-biotic complex
EP87112861A EP0259780B1 (de) 1986-09-11 1987-09-03 Methode für selektiven Zuwachs des Anteils der gewönlichen Hauptkomponente des antibiotischen Komplexes A/16686

Publications (1)

Publication Number Publication Date
ATE87335T1 true ATE87335T1 (de) 1993-04-15

Family

ID=10604035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87112861T ATE87335T1 (de) 1986-09-11 1987-09-03 Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.

Country Status (14)

Country Link
US (1) US5925550A (de)
EP (1) EP0259780B1 (de)
JP (1) JP2728406B2 (de)
KR (1) KR960013576B1 (de)
AT (1) ATE87335T1 (de)
CA (1) CA1301689C (de)
DE (1) DE3784988T2 (de)
DK (1) DK166628B1 (de)
ES (1) ES2038974T3 (de)
GB (1) GB8621911D0 (de)
HU (1) HU198229B (de)
IE (1) IE60223B1 (de)
IL (1) IL83736A (de)
ZA (1) ZA876773B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US20040062757A1 (en) * 2001-06-05 2004-04-01 Finegold Sydney M. Method of testing gastrointestinal diseases associated with species of genus clostridium
US20020013270A1 (en) * 2000-06-05 2002-01-31 Bolte Ellen R. Method for treating a mental disorder
CA2394616C (en) 2000-10-13 2007-05-15 Ecopia Biosciences Inc. Gene cluster for ramoplanin biosynthesis
US7144858B2 (en) * 2002-05-31 2006-12-05 The Trustees Of The University Of Pennsylvania Antibacterial compounds and methods for treating Gram positive bacterial infections
AU2003240545A1 (en) * 2002-06-06 2003-12-22 Therapeutics Corporation Genome Use of ramoplanin to treat diseases associated with the use of antibiotics
WO2004017925A2 (en) * 2002-08-23 2004-03-04 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
US20050090433A1 (en) * 2002-11-18 2005-04-28 Vicuron Pharmaceuticals, Inc Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
CA2523573A1 (en) * 2003-04-25 2004-11-11 Oscient Pharmaceuticals Corporation Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
CN101024661B (zh) * 2006-02-24 2010-05-12 上海医药工业研究院 一种雷莫拉宁三种单组分的分离方法
US9707207B2 (en) 2010-05-26 2017-07-18 The United States Of America As Represented By The Department Of Veterans Affairs Method for diagnosing, preventing, and treating neurological diseases
WO2013006960A1 (en) 2011-07-13 2013-01-17 Foodchek Systems, Inc. Culture medium, method for culturing listeria, and method for detecting listeria
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7031T1 (de) * 1980-08-16 1984-04-15 Gruppo Lepetit S.P.A. Antibiotikum a/16686 faktor a2, verfahren zu dessen herstellung und die gleichzeitig hergestellten antibiotika a/16686 faktoren a1 und a3.
JPH0612434B2 (ja) * 1985-05-17 1994-02-16 富士写真フイルム株式会社 ハロゲン化銀カラ−写真感光材料の処理方法
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
ES2072348T3 (es) * 1989-11-07 1995-07-16 Lepetit Spa Procedimiento de recuperacion del antibiotico a/16686.

Also Published As

Publication number Publication date
EP0259780A2 (de) 1988-03-16
ZA876773B (en) 1988-06-29
JP2728406B2 (ja) 1998-03-18
IL83736A (en) 1993-02-21
DE3784988T2 (de) 1993-07-08
DK461787A (da) 1988-03-12
CA1301689C (en) 1992-05-26
IE60223B1 (en) 1994-06-15
HUT46362A (en) 1988-10-28
HU198229B (en) 1989-08-28
US5925550A (en) 1999-07-20
ES2038974T3 (es) 1993-08-16
DK166628B1 (da) 1993-06-21
IE872421L (en) 1988-03-11
KR880004094A (ko) 1988-06-01
GB8621911D0 (en) 1986-10-15
DE3784988D1 (de) 1993-04-29
IL83736A0 (en) 1988-02-29
KR960013576B1 (ko) 1996-10-09
EP0259780A3 (en) 1990-07-04
DK461787D0 (da) 1987-09-04
JPS6377891A (ja) 1988-04-08
EP0259780B1 (de) 1993-03-24

Similar Documents

Publication Publication Date Title
ATE87335T1 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
DE3880438D1 (de) Verfahren zur herstellung von aktivkohle.
DE3587617D1 (de) Verfahren zur herstellung von bipolaren halbleiteranordnungen.
DE3688336D1 (de) Verfahren zur herstellung von organischen saeuren unter verwendung von mikroorganismen.
DE3782590D1 (de) Methode fuer selektiven zuwachs des anteils der gewoehnlichen hauptkomponente des antibiotischen komplexes a 40926.
DE3483252D1 (de) Verfahren zur induktion von antitumorimmunozyten, verfahren zur herstellung von antitumorimmunozyten und durch das verfahren hergestellte antitumorimmunozyten.
DE3776464D1 (de) Verfahren zur herstellung von maleimiden.
ATE95836T1 (de) Zum abbau von glycosaminoglycan faehige enzymzusammensetzung und verfahren zur herstellung dieser zusammensetzung.
DE3582368D1 (de) Verfahren zur herstellung von epoxyden mittels mikroorganismen.
DE3882842D1 (de) Methode zur herstellung von cineolen.
ATE152176T1 (de) Verfahren zum regeln des norleucingehalts in polypeptiden
DE3874961D1 (de) Verfahren zur herstellung von endo-alpha-n-acetylgalactosaminidase durch mikroorganismen.
DE3888216D1 (de) Methode zur Herstellung von aminokohlenwasserstoff-substituierten Ketoximosilanen.
DE3881103D1 (de) Verfahren zur herstellung von 1,3,2-oxazaphosphorinan.
DE3875885D1 (de) Methode zur herstellung von polycyclischen 1,3-thiazolidinen.
DE3868160D1 (de) Verfahren zur herstellung von carbonsaeuren.
DE3884922D1 (de) Verfahren zur Herstellung von thermostabilen alpha-Amylasen durch Kultivierung von überproduzierenden Mikroorganismen.
DE3862588D1 (de) Verfahren zur herstellung von 7,7,8,8,-tetracyanochinodimethan.
ATE91507T1 (de) Fermentationsverfahren zur herstellung von 2-keto-l-gulonsaeuren.
ATA48089A (de) Verfahren zur herstellung des enzymes myeloperoxydase
ATE83506T1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy- 17-keto-steroiden.
ATE62895T1 (de) Verfahren zur herstellung von kohlenstoffmolekularsieben.
HUT49151A (en) Process for production of biotinilated proteins
ATE50795T1 (de) Verfahren zur bakteriellen herstellung von gluconsaeure.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee